Copp SW, Hirai DM, Ferreira LF, Poole DC, Musch TI. Progressive chronic heart failure slows the recovery of microvascular O2 pressures after contractions in the rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol 299: H1755-H1761, 2010. First published September 3, 2010; doi:10.1152/ajpheart.00590.2010.-Chronic heart failure (CHF) induces muscle fiber-type specific alterations in skeletal muscle O2 delivery and utilization during metabolic transitions. As a result, the recovery of microvascular PO 2 (PmvO 2 ) is prolonged in slow-twitch skeletal muscle but not fast-twitch skeletal muscle in rats with CHF. We tested the hypothesis that CHF slows Pmv O 2 recovery in rat skeletal muscle of a mixed fiber-type analogous to human locomotory muscles and that the degree of slowing correlates with central indexes of heart failure. Healthy control [n ϭ 6, left ventricular end-diastolic pressure (LVEDP): 10 Ϯ 1 mmHg], moderate CHF (n ϭ 6, LVEDP: 18 Ϯ 2 mmHg), and severe CHF (n ϭ 4, LVEDP: 34 Ϯ 2 mmHg) female Sprague-Dawley rats had their right spinotrapezius muscles (41% type I, 7% type IIa, and 52% type IIb and d/x) exposed, and PmvO 2 was measured via phosphorescence quenching during 180 s of recovery from 180 s of electrically induced twitch contractions (1 Hz, 4 -6 V). CHF progressively slowed the mean response time (MRT; the time to reach 63% of the overall dynamic response) of PmvO 2 recovery (MRToff; control: 60.2 Ϯ 6.9, moderate CHF: 72.8 Ϯ 6.6, and severe CHF: 109.8 Ϯ 6.6 s, P Ͻ 0.05 for all). MRT off correlated positively with central hemodynamic (LVEDP: r ϭ 0.76, P Ͻ 0.01) and morphological (right ventricle-to-body weight ratio: r ϭ 0.74, P Ͻ 0.01; and lung weight-to-body weight ratio: r ϭ 0.79, P Ͻ 0.01) indexes of heart failure. The present investigation suggests that slowed PmvO 2 kinetics during recovery in CHF constitutes a mechanistic link between impaired circulatory and metabolic recovery after contractions in CHF. skeletal muscle; oxygen delivery; myocardial infarction; left ventricular end-diastolic pressure; phosphorescence quenching; partial pressure of oxygen CHRONIC HEART FAILURE (CHF) is a complex clinical syndrome hallmarked by impaired exercise and work capacity, particularly during the repetitive activities of daily living. Experimental evidence supports that CHF induces central and peripheral derangements that reduce O 2 availability to working muscle(s) at the onset and during recovery from exercise (8, 43, 50) , which mechanistically may underlie the reduced exercise tolerance. For example, given its regulatory role in skeletal muscle metabolism (22), decreases in O 2 availability increase the reliance on "anaerobic energy" during (40, 48) and prolong metabolic recovery after (9, 37, 48) exercise.
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While CHF-related research has focused primarily on altered rest-exercise transitions, less is known regarding the mechanisms underlying the altered off-transient responses (for review, see Ref. 25) . This information is of great clinical utility given that the recovery kinetics of pulmonary O 2 utilization (V O 2 ) are more reproducible (23) and may be determined with a higher degree of fidelity (26) than onset kinetics in CHF patients. Moreover, at similar relative exercise intensities, CHF-induced alterations in off-transient pulmonary V O 2 responses may exist despite similar on-transient responses compared with healthy controls (45) . These data support that altered off-transient responses constitute a powerful prognostic indicator of functional capacity (10) , and, therefore, analysis of the mechanistic bases of the slowed pulmonary V O 2 recovery is warranted.
Our laboratory has previously demonstrated that progressive CHF increasingly slows the recovery of microvascular PO 2 (34) . This is important because a slow Pmv O 2 recovery lowers the pressure head for capillary-myocyte O 2 transfer according to Fick's law of diffusion and impairs the recovery of the intracellular metabolic milieu, thereby increasing muscle fatigability during subsequent contraction bouts (27) . While these previous results have provided important mechanistic insights into the divergent effects of CHF on the recovery of Pmv O 2 in muscles of contrasting fiber types, it is not known whether the recovery of Pmv O 2 is slowed in muscle more representative of human locomotor muscle. In this regard, the rat spinotrapezius muscle possesses a mixed-fiber type composition [41% type I, 7% type IIa, and 52% type IIb and d/x, (11) 
METHODS
Sixteen female Sprague-Dawley rats (312 Ϯ 7 g) were studied in the present investigation. Rats were divided into the following groups: healthy controls (control group; n ϭ 6) and rats that received a myocardial infarction (CHF group; n ϭ 10). These 16 animals represent a subset of rats from a larger cohort (15) in which an off-transient response was successfully collected subsequent to measurements of Pmv O 2 during contractions. Off-transient determination was precluded in the other animals due to technical issues (i.e., movement of the measurement plane during contractions). All rats were housed at Kansas State University with food and water provided ad libitum. All procedures and protocols described herein were approved by the Institutional Animal Care and Use Committee and were conducted according to guidelines set forth by the National Institutes of Health.
Surgical procedures. Myocardial infarction was induced in CHF rats via ligation of the left main coronary artery (36) . Initially, CHF rats were anesthetized with a 5% isoflurane-O 2 mixture and intubated for mechanical ventilation with a rodent respirator (model 680, Harvard Instruments, Holliston, MA) for the duration of the infarction procedure. The heart was accessed through a left thoracotomy in the fifth intercostal space. The left main coronary artery was ligated with 6-0 silk suture ϳ1-2 mm distal to the edge of the left atrium. The final experimental protocol was initiated 7-10 wk after surgery. Given there were no differences in cardiovascular responses between shamoperated and nonsham-operated controls (47) , animals in the control group were not subjected to any surgical procedure.
For the final experimental protocol, control and CHF rats were anesthetized with pentobarbital sodium (50 mg/kg administered intraperitoneally to effect), monitored continuously via toe-pinch and blink reflexes with anesthesia supplemented as necessary, and placed on a heating pad to maintain core temperature at 38°C (measured via a rectal probe). The carotid artery was cannulated, and a 2-Fr cathetertipped pressure transducer (Millar Instruments, Houston, TX) was advanced into the left ventricle (LV) for measurements of systolic and diastolic pressures. Upon completion of the measurements, the transducer was removed, and the carotid artery was recannulated with a catheter (polyethylene-50, Intra-Medic polyethylene tubing, Clay Adams Brand, Sparks, MD) for the measurement of mean arterial pressure (MAP), infusion of the phosphorescent probe, and arterial blood sampling. The overlying skin and fascia were then removed carefully from the mid-dorsal-caudal region of each rat, and the right spinotrapezius muscle was exposed in a manner that ensured the integrity of the vascular and neural supply to the muscle (2). Silver wire electrodes were then sutured (6-0 silk) to the rostral (cathode) and caudal (anode) regions of the muscle. The exposed spinotrapezius muscle was continuously superfused with warmed (38°C) KrebsHenseleit bicarbonate-buffered solution equilibrated with 5% CO 2-95% N2, and the surrounding exposed tissue was covered with Saran Wrap (Dow Industries, Indianapolis, IN).
Experimental protocol. The experimental protocol was exactly as previously described (15) with the present analysis reflecting the recovery of Pmv O 2 from an electrically induced contraction bout of the spinotrapezius muscle after locally superfused physiological KrebsHenseleit solution. Initially, the phosphorescent probe palladium meso-tetra(4-carboxyphenyl)porphyrin dendrimer (R2: 15-20 mg/kg dissolved in 0.4 ml saline) was infused via the carotid artery catheter. After a brief stabilization period (ϳ10 -15 min), the common end of the light guide of a frequency domain phosphorimeter (PMOD 1000, Oxygen Enterprises, Philadelphia, PA) was positioned ϳ2-4 mm superficial to the dorsal surface of the exposed right spinotrapezius muscle over a randomly selected muscle field absent of large vessels. This region contained principally capillary blood, and Pmv O 2 was continuously measured via phosphorescence quenching (see below) and reported at 2-s intervals throughout the duration of the 180-s contraction protocol (1 Hz, 4 -6 V, 2-ms pulse durations) elicited via a Grass stimulator (model S88, Quincy, MA) and for a minimum of 180 s during the immediate postcontraction recovery period. After recovery, an arterial blood sample was drawn from the carotid artery catheter, the animal was killed by a pentobarbital sodium overdose, the thorax was opened, and the lungs and heart were removed. The right ventricle (RV) was separated from the LV and right atria, and both the lungs and RV were weighed to obtain the RV weight-to-body weight and lung weight-to-body weight ratios. Pfeffer et al. (41) demonstrated that the RV weight-to-body weight ratio is a better indicator of ventricular dysfunction than the LV weight-to-body weight ratio.
Pmv O 2 measurement and curve-fitting. The principles of the phosphorescence quenching technique have been previously described (3, 5, 29, 33, 44) . Briefly, the Stern-Volmer relationship permits the calculation of Pmv O 2 through the direct measurement of a phosphorescence lifetime via the following equation described by Rumsey et al. (44):
where kQ is the quenching constant (expressed in mmHg Ϫ1 ·s Ϫ1 ) and °and are the phosphorescence lifetimes in the absence of O2 and the ambient O2 concentration, respectively. For R2, kQ is 409 mmHg Ϫ1 ·s Ϫ1 and °is 601 s (29); these characteristics do not change over the physiological range of pH and temperature in the rat in vivo, and, therefore, the phosphorescence lifetime is solely affected by O 2 pressure (29, 44) . The R2 probe binds to albumin and is thus uniformly distributed throughout the plasma. This characteristic ensures that R2 remains within the microvascular space and does not filter into the surrounding tissue, thus ensuring the valid measurement of Pmv O 2 (42) .
Curve fitting of the measured PmvO 2 was performed with commercially available software (SigmaPlot 9.01, Systat Software, San Jose, CA), and the data were fit with either a one-or two-component model as described below:
where PmvO 2 (t) is PmvO 2 at any given time t, PmvO 2 (end-con) is the prerecovery contracting steady state as determined from average Pmv O 2 over the last ϳ15 s of contractions, ⌬1 and ⌬2 are the amplitudes for the first and second components, respectively, TD1 and TD2 are the time delays for each component, and 1 and 2 are the time constants (i.e., time to 63% of the final response value) for each component. Goodness of fit (including, specifically, the selection of a one-or two-component model; see Ref. 33 for more detail) was determined using the following criteria: 1) the coefficient of determination (r 2 ), 2) sum of the squared residuals, and 3) visual inspection and analysis of the model fits to the data. The mean response time (MRT; a parameter describing the overall dynamic response) of the recovery period (MRT off) was calculated to provide an index of the overall kinetic response according to the following equations (31):
where ⌬tot is the total amplitude of PmvO 2 during recovery (i.e., ⌬1 ϩ ⌬2). Additionally, the time taken to reach 63% of the final response PmvO 2 was determined independently from the modeling procedures (T63) to ensure appropriateness of the model fits. Specifically, the raw Pmv O 2 data were interpolated, and the time coinciding with 63% of the total recovery amplitude (⌬ total PmvO 2 ) was determined. MRToff is highly reproducible during recovery periods from repeated contractions bouts separated by 20 min (within-animal coefficient of variation: 8 Ϯ 3 s, n ϭ 8) with no ordering effect (overall within-animal difference: 1 Ϯ 5 s, P Ͼ 0.05). Data analysis. CHF rats were further divided into moderate (n ϭ 6) or severe (n ϭ 4) categories as described by Diederich et al. (13) . Specifically, CHF rats were placed into the severe CHF category if LV end-diastolic pressure (LVEDP), RV weight-to-body weight ratio, and lung weight-to-body weight ratio were all greater than 4 SDs from the mean of control animals. All other CHF rats were placed in the moderate CHF group. Off-transient data were compared with the ontransient (MRT on) from the same animals in which the recovery was analyzed. MRT, T63, and MAP were compared among (control vs. moderate CHF vs. severe CHF) and within (MRT and T63: on-transient vs. off-transient and MAP: end-contractions vs. endrecovery) groups with two-way ANOVAs. All other comparisons among groups were analyzed with one-way ANOVAs. Where differences were detected, a Student-Newman-Keuls post hoc test was performed. Directional hypotheses were tested via one-tailed tests, whereas all other comparisons were tested against nondirectional hypotheses via two-tailed tests. Standard linear regression and Pearson's product-moment correlations were used to examine the relationships among central indexes of heart failure, MRT off, and PmvO 2 response asymmetry (MRToff-on) when all individual animals were combined. Data are presented as means Ϯ SE. The significance level was set at P Ͻ 0.05.
RESULTS
Body mass was not different (P Ͼ 0.05) among groups (control: 310 Ϯ 14 g, moderate CHF: 313 Ϯ 6 g, and severe CHF: 314 Ϯ 16 g).
Hemodynamic and morphological indexes of heart failure. Hemodynamic and morphological indexes of heart failure are shown in Table 1 . Moderate CHF rats demonstrated a significantly elevated LVEDP and RV weight-to-body weight ratio, but not lung weight-to-body weight ratio, compared with control rats. In severe CHF rats, LVEDP, RV weight-to-body weight ratio, and lung weight-to-body weight ratio were all elevated compared with both control and moderate CHF groups.
Arterial blood sampling and MAP. There were no differences in arterial O 2 saturation (control: 93 Ϯ 1%, moderate CHF: 95 Ϯ 1%, and severe CHF: 95 Ϯ 2%), systemic hematocrit (control: 41 Ϯ 1, moderate CHF: 43 Ϯ 2, and severe CHF: 42 Ϯ 2), or pH (control: 7.45 Ϯ 0.02, moderate CHF: 7.42 Ϯ 0.02, and severe CHF: 7.46 Ϯ 0.01) among groups (P Ͼ 0.05 for all). Within each group, there were no differences between the end-contractions and end-recovery MAP.
However, when compared among groups, MAP of the severe CHF rats was significantly lower (P Ͻ 0.05) than control and moderate CHF rats at the end of the contractions and recovery period ( Table 1) .
Effects of CHF on the spinotrapezius muscle Pmv O 2 off-transient. The effects of moderate and severe CHF on Pmv O 2 during recovery from contractions of the spinotrapezius muscle are shown in Table 2 , and the average data from each group are shown in Fig. 1 . The recovery profiles in all six control rats were well fit with a one-component model, whereas the more complex two-component model fit was indicated in the majority of CHF rats (moderate: 3 of 6 rats and severe: 3 of 4 rats). recovery was slower than control and moderate CHF rats (P Ͻ 0.05 for both). There were significant correlations (P Ͻ 0.01 for all) between MRT off and LVEDP (r ϭ 0.76; Fig. 2 ), RV weight-to-body weight ratio (r ϭ 0.74), and lung weight-tobody weight ratio (r ϭ 0.79). Importantly, the analysis and interpretation of the recovery kinetics of Pmv O 2 and the correlations with indexes of CHF were not different whether the model-dependent (MRT off ) or model-independent (T 63 ) parameters were used. This observation establishes confidence in the modeling procedures used.
Effects of CHF on spinotrapezius muscle Pmv O 2 on-off asymmetry. Significantly slower MRT off versus the corresponding MRT on (i.e., Pmv O 2 on-off asymmetry) was observed in all groups (Fig. 3) . However, the difference between MRT off and MRT on (MRT off-on ) was not different (P Ͼ 0.05) between control and moderate CHF animals, whereas it was increased (P Ͻ 0.05) in severe CHF animals compared with both control and moderate CHF animals. There were significant correlations (P Ͻ 0.01 for all) between MRT off-on and LVEDP (r ϭ 0.69; Fig. 4) , RV weight-to-body weight ratio (r ϭ 0.75), and lung weight-to-body weight ratio (r ϭ 0.75). There was no correlation (r ϭ Ϫ0.11, P ϭ 0.70) between MRT off and MRT on .
DISCUSSION
Three principal novel findings emerged from the present investigation: 1) progressive CHF increasingly slows the recovery of Pmv O 2 in mixed fiber-type rat skeletal muscle, 2) MRT off and MRT off-on significantly correlate with central hemodynamic (LVEDP) and morphological (RV weight-to-body weight and lung weight-to-body weight ratios) indexes of heart failure, and 3) a slower MRT off may be evident in the spinotrapezius muscle of CHF rats despite no clearly discernable effects of CHF on MRT on in these animals ( Fig. 3, top; see also Ref. 15 ). These results provide mechanistic insights into the slowed pulmonary V O 2 recovery as well as delayed phosphocreatine (PCr) resynthesis after exercise in CHF patients and likely help explain the resultant exercise intolerance during repetitive activities. Moreover, the present results are directly relevant for future investigations that use animal models to explore therapeutic treatments to alleviate microvascular dysfunction in CHF. Specifically, investigating off-transient kinetics may prove more efficacious in detecting potential beneficial effects of pharmacological and nonpharmacological therapies on microvascular function.
Pmv O 2 off-kinetics in CHF: relationship with the literature. In the present study, CHF induced marked alterations in the Pmv O 2 recovery from contractions in the mixed fiber-type rat spinotrapezius muscle compared with healthy controls. Specifically, CHF progressively slowed the Pmv O 2 recovery (MRT off and T 63 ), which is similar to previous findings in the slowtwitch soleus muscle but not in the fast-twitch peroneal muscle from CHF rats (34) . While our previous investigation (34) is important for highlighting the dramatic fiber-type influences on the recovery of Pmv O 2 in skeletal muscles of CHF rats (see Fig. 5 ), it does not provide clear insights into tissue that is more representative of human locomotor muscle(s). The present observation that progressive CHF slows the increase in Pmv O 2 during the recovery from contractions in the mixed fiber-type spinotrapezius muscle is consistent with the slowed pulmonary V O 2 (8, 9, 45) , skeletal muscle oxygenation (8, 17, 24) , and PCr (9, 24, 37, 48) recovery kinetics after exercise in CHF patients. The Pmv O 2 asymmetry between the on-and off-transients (MRT off-on ) evident for all groups in the present investigation was expected based on similar observations in young healthy (33) , aged (19) , and slow-twitch CHF (34) muscle. Interestingly, the progressive asymmetry suggested by the data are driven solely by a systematic lengthening of the recovery period rather than a combination of the speeding of the onset and slowing of the offset as reported for aged (19) and CHF slow-twitch (34) muscle.
The correlations between central indexes of cardiac function and MRT off and MRT off-on when all animals were combined are highly novel. The present research model used submaximal electrical stimulation of a small muscle mass such that central cardiac (dys)function via cardiac output was not expected to have any direct bearing on Pmv O 2 during recovery. Therefore, these correlations suggest that progressive CHF induces peripheral maladaptations that impact recovery processes negatively and occur generally in proportion to central CHF dysfunction. However, it is noteworthy that these correlations appear principally driven by the presence of the severe CHF group and may not be obligatory within groups or when healthy and moderate CHF rats are investigated in separatum.
CHF has not produced consistent alterations in the onkinetics in spinotrapezius muscle, with studies reporting a slowing (4), speeding (4, 13) , and/or no change (15) compared with healthy controls, and the mechanisms accounting for these observations are unclear. It is worth noting, however, that the low Pmv O 2 (end-con) and Pmv O 2 (end-rec) in severe CHF rats in the present study is consistent with lower absolute Pmv O 2 values at rest and during contractions in these same rats (15) and other severe CHF populations (13) . It also must be considered that, whereas clusters of aberrant on-responses are found in CHF, these vary among animals such that differences from healthy animals are blurred in the mean data. This does not appear to be true for the off-transient.
Mechanisms of microvascular dysfunction during recovery in CHF.
In healthy rats, the recovery of Pmv O 2 after contractions is characterized by a brief time delay in which Q O 2 and V O 2 are likely decreasing in direct proportion to one another followed by a systematic rise in Pmv O 2 to the steady-state value during which the dynamics of V O 2 may occur faster than that of Q O 2 (51) . The slower Q O 2 recovery acts to elevate capillarymyocyte O 2 driving pressure and facilitate metabolic recovery. As such, any CHF-induced maladaptation that reduces postexercise blood flow relative to local V O 2 would be expected to reduce Pmv O 2 during the recovery period. Experimental evidence has demonstrated that CHF results in the attenuation (21, Fig. 5 . Effects of CHF on MRToff in muscles of varying fiber-type composition (11) expressed relative to healthy CON values. Values were calculated from group means for the peroneal, soleus (34) , and spinotrapezius (present study) muscles. Note the progressive lengthening of the PmvO 2 recovery in MOD CHF animals as the percentage of type I muscle fibers increases, whereas in SEV CHF rats there appears to be a "threshold" influence of fiber type on the duration of PmvO 2 recovery. *P Ͻ 0.05 vs. CON values. 30) and/or redistribution (36) of blood flow during exercise in concert with reduced Q O 2 to the tissues during recovery (50) . The lower postexercise Q O 2 correlates with delayed metabolic (PCr) recovery (50) and is consistent with peripheral vascular dysfunction consequent to neurohumoral dysregulation (52) and reduced nitric oxide (NO) bioavailability (14) . The role of reduced NO bioavailability in CHF rats is supported by the observation that in healthy rats local superfusion of N-nitro-Larginine methyl ester (L-NAME; an inhibitor of NO synthase) slows the recovery of Pmv O 2 (18) , resulting in a recovery profile closely resembling that found in CHF rats. This suggests that in CHF rat spinotrapezius muscle the superfusion of L-NAME would have little or no effect on Pmv O 2 recovery kinetics. Additionally, CHF slows the Pmv O 2 recovery in the slow-twitch soleus but not fast-twitch peroneal muscles (34) . Given that NO plays a larger role in vessels supplying predominantly slow-twitch compared with fast-twitch muscle (20, 32, 35) , this observation further supports the influence of reduced NO bioavailability on altered Pmv O 2 recovery dynamics in CHF.
The inability of CHF patients to effectively match Q O 2 to O 2 demands during exercise transitions consequent to central and peripheral circulatory alterations prolongs metabolic (9, 37, 48) and central hemodynamic (38, 49) recovery. These alterations are reflected in the delayed recovery characteristic of pulmonary V O 2 kinetics, which correlates with exercise intolerance and reduced functional capacity (39) . Additionally, CHF impairs oxidative enzyme activity [severe CHF (12) ], reduces mitochondrial creatine kinase expression (16) , increases the expression of inducible NO synthase (1, 16) , and alters Ca 2ϩ handling by the sarcoplasmic reticulum (7) within skeletal muscle. These intracellular alterations are expected to further retard metabolic recovery.
Experimental considerations. CHF elicits myriad complications affecting both muscle Q O 2 and V O 2 . It must be considered that CHF subjects may be markedly heterogeneous with regard to symptoms and degree of functional impairment, thus challenging research efforts. For example, as shown in Fig. 2 , slower Pmv O 2 recovery kinetics may not be an obligatory phenomenon in all moderate CHF rats. Notwithstanding these considerations, an important contribution of the present work is the observation that Pmv O 2 off-kinetics may be slowed despite no consistent alterations in the on-transient, even in rats with the most severe heart failure (4, 13, 15) . We propose that the analysis of Pmv O 2 recovery kinetics in the spinotrapezius muscle of CHF rats constitutes an important research tool with which to perform mechanistic investigations into the effects of CHF on skeletal muscle microvascular dysfunction and potential therapeutic interventions.
The severe CHF group exhibited significantly reduced MAP at the end of contractions and at the end of the recovery period compared with both control and moderate CHF rats (Table 1) . Our laboratory (6) has previously demonstrated that arterial hypotension does not affect Pmv O 2 kinetics parameters until MAPs of Ͻ70 mmHg are reached. Therefore, we are confident that the prolonged Pmv O 2 recovery dynamics evident in severe CHF rats are the direct result of the CHF-related vascular and muscle pathology per se and not secondary to the lower MAP.
Summary and conclusions. Consistent with our hypotheses, the present study demonstrated that progressive CHF increasingly slows the recovery of Pmv O 2 after contractions in the mixed fiber-type rat spinotrapezius muscle and that the degree of slowing positively correlates with central indexes of heart failure. Moreover, the present investigation identified, for the first time, that CHF may alter the off-kinetics in rat skeletal muscle independent of consistent alterations in Pmv O 2 onkinetics. As such, a mechanistic link is suggested between altered circulatory control and the prolonged metabolic recovery after exercise in CHF patients, which is in accordance with the delayed recovery of pulmonary V O 2 kinetics evident in this population. Elucidation of the mechanisms underlying the slowed kinetics of pulmonary V O 2 recovery in CHF patients constitutes an important step in the development of pharmacological and nonpharmacological (i.e., exercise training protocols) therapies designed to mitigate the pernicious effects of this disease on exercise performance and quality of life.
